Topics covered include:
- What is the evidence and implications related to G-CSF having a role in progression?
- Is it safe for doctors to use G-CSF stimulating agents for patients with neutropenia?
- What are the current and future therapeutic opportunities related to the G-CSF receptor and cancer stem-like cells?